Polymyxin B-Induced Skin Hyperpigmentation
Joint Authors
Wen, Xueke
Luo, Chunliu
Lyu, Weitao
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-09-18
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Polymyxin B-induced skin hyperpigmentation is a rare adverse drug reaction (ADR).
In this report, we present the case of a patient who underwent an abscess resection with right epididymitis, in which a multidrug-resistant Klebsiella pneumoniae infection (KPI) is formed.
The patient was treated with polymyxin B and subsequently developed skin hyperpigmentation and desquamation.
The desquamation improved and the pigmentation gradually returned to normal after sixty days after the withdrawal of polymyxin B.
American Psychological Association (APA)
Wen, Xueke& Luo, Chunliu& Lyu, Weitao. 2020. Polymyxin B-Induced Skin Hyperpigmentation. Case Reports in Medicine،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1148557
Modern Language Association (MLA)
Wen, Xueke…[et al.]. Polymyxin B-Induced Skin Hyperpigmentation. Case Reports in Medicine No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1148557
American Medical Association (AMA)
Wen, Xueke& Luo, Chunliu& Lyu, Weitao. Polymyxin B-Induced Skin Hyperpigmentation. Case Reports in Medicine. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1148557
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1148557
